A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment.
2015-09-20

2015. Han AR, Lee JY, Kim HJ, Min WS, Park G, Kim SH. Oncology Reports 34(6): 2880-8.